The import of composite diagnostic or laboratory reagents to the US is forecasted to show a consistent upward trend from 2024 to 2028, starting at $4.6767 billion in 2024 and rising to $5.2501 billion by 2028. As of 2023, the actual import value was slightly below the 2024 forecast.
Year-over-year growth is forecasted to gradually increase: approximately 3.10% in 2025, 3.00% in 2026, 2.86% in 2027, and around 2.72% in 2028. The compounded annual growth rate (CAGR) for the five-year period is projected to be modest, reflecting steady growth in the sector.
Future trends to watch:
- Technological advancements in diagnostic reagents that could influence demand.
- Regulatory changes impacting the importation of medical products.
- Global economic conditions and their effect on international trade policies.
